{"id":"W4386784022","doi":"10.1158/1557-3265.aacrahns23-pr11","title":"Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ipilimumab; Internal medicine; Oncology; Regimen; Cohort; Immunotherapy; Cyclophosphamide; Cancer; Chemotherapy; Gastroenterology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000999445,0.001124095,0.00111336,0.0002119484,0.0003315614,0.0008706777,0.0008971659,0.0009396747,0.003969635],"category_scores_gemma":[0.0004405792,0.0003468531,0.0007778143,0.0002071982,0.0007169758,0.0006844762,0.0003208194,0.003219255,0.0007358351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006453875,"about_ca_system_score_gemma":0.001572808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000624653,"about_ca_topic_score_gemma":0.001345598,"domain_scores_codex":[0.9997728,0.0001045948,0.00001197277,0.00005050676,0.00001702216,0.00004315588],"domain_scores_gemma":[0.9996384,0.00005339698,0.00006246688,0.00003315841,0.00002379726,0.0001886962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8128046,0.06099059,0.003120727,0.0007917615,0.0006608088,0.0001793775,0.0002103009,0.002276007,0.04993349,0.0003749845,0.003924445,0.06473293],"study_design_scores_gemma":[0.5588679,0.427605,0.00342494,0.00003242626,0.0002857642,0.0001724039,0.00004329812,0.0009969505,0.006665806,0.0001602906,0.001727772,0.00001749986],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944797,0.0008260985,0.0004197053,0.0003138541,0.0001104706,0.00195842,0.0007086605,0.00007962112,0.001103449],"genre_scores_gemma":[0.9911886,0.0009368413,0.001038233,0.0004190327,0.00009528349,0.002060454,0.001438244,0.00001774786,0.002805552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003969635,"threshold_uncertainty_score":0.0132798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1920085928725171,"score_gpt":0.5151618163253213,"score_spread":0.3231532234528042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}